- Home
- PTGX vs EVCM Comparison
PTGX vs EVCM Comparison
Compare PTGX & EVCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTGX | EVCM |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 1.4B |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PTGX | EVCM |
|---|---|---|
| Price | $139.40 | $9.87 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 8 |
| Target Price | ★ $174.69 | $11.00 |
| AVG Volume (30 Days) | ★ 535.2K | 151.7K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 145.45 |
| EPS | ★ 2.35 | 0.09 |
| Revenue | N/A | ★ $588,907,000.00 |
| Revenue This Year | $1,078.44 | $4.16 |
| Revenue Next Year | N/A | $4.89 |
| P/E Ratio | ★ $60.03 | $90.39 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $62.24 | $6.21 |
| 52 Week High | $160.81 | $14.41 |
Technical Indicators
Market Signals| Indicator | PTGX | EVCM |
|---|---|---|
| Relative Strength Index (RSI) | 44.31 | 58.87 |
| Support Level | $132.37 | $8.98 |
| Resistance Level | $142.20 | $12.52 |
| Average True Range (ATR) | 4.59 | 0.56 |
| MACD | -0.44 | 0.23 |
| Stochastic Oscillator | 39.61 | 100.00 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
About EVCM EverCommerce Inc.
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. The Company served more than 745,000 customers across three core verticals: EverPro for Home Services; EverHealth for Health Services; and EverWell for Wellness Services. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty.